Literature DB >> 22507878

Management of high-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus.

Sachin Wani1, Dayna Early, Steve Edmundowicz, Prateek Sharma.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22507878     DOI： 10.1016/j.cgh.2012.03.030

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  11 in total

1.  Intravoxel incoherent motion diffusion-weighted imaging of resectable oesophageal squamous cell carcinoma: association with tumour stage.

Authors:  Yu-Cheng Huang; Tian-Wu Chen; Xiao-Ming Zhang; Nan-Lin Zeng; Rui Li; Yu-Lian Tang; Fan Chen; Yan-Li Chen
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

Review 2.  Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.

Authors:  Sachin Wani; V Raman Muthusamy; Nicholas J Shaheen; Rena Yadlapati; Robert Wilson; Julian A Abrams; Jacques Bergman; Amitabh Chak; Kenneth Chang; Ananya Das; John Dumot; Steven A Edmundowicz; Glenn Eisen; Gary W Falk; M Brian Fennerty; Lauren Gerson; Gregory G Ginsberg; David Grande; Matt Hall; Ben Harnke; John Inadomi; Janusz Jankowski; Charles J Lightdale; Jitin Makker; Robert D Odze; Oliver Pech; Richard E Sampliner; Stuart Spechler; George Triadafilopoulos; Michael B Wallace; Kenneth Wang; Irving Waxman; Srinadh Komanduri
Journal:  Am J Gastroenterol       Date:  2017-06-01       Impact factor: 10.864

3.  The safety and efficacy of endoscopic submucosal dissection for treating early oesophageal carcinoma: a meta-analysis.

Authors:  H Y Wang; X Zeng; S Y Bai; K Pu; Y Zheng; R Ji; Q H Guo; Q L Guan; Y P Wang; Y N Zhou
Journal:  Ann R Coll Surg Engl       Date:  2020-08-21       Impact factor: 1.891

Review 4.  Endoscopic Treatment of Early-Stage Esophageal Cancer.

Authors:  Mariam Naveed; Nisa Kubiliun
Journal:  Curr Oncol Rep       Date:  2018-07-30       Impact factor: 5.075

5.  Associated risk factor analysis and the prognostic impact of positive resection margins after endoscopic resection in early esophageal squamous cell carcinoma.

Authors:  Yong Feng; Wei Wei; Shuo Guo; Bao-Qing Li
Journal:  Exp Ther Med       Date:  2022-05-20       Impact factor: 2.751

Review 6.  [Limitations of surgery for cancer of the upper gastrointestinal tract].

Authors:  E Karakas; C Oetzmann von Sochaczewski; T Haist; M Pauthner; D Lorenz
Journal:  Chirurg       Date:  2014-03       Impact factor: 0.955

7.  Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study.

Authors:  Sachin Wani; Jennifer Drahos; Michael B Cook; Amit Rastogi; Ajay Bansal; Roy Yen; Prateek Sharma; Ananya Das
Journal:  Gastrointest Endosc       Date:  2013-09-20       Impact factor: 9.427

8.  Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data.

Authors:  Nicholas Swart; Roberta Maroni; Beth Muldrew; Peter Sasieni; Rebecca C Fitzgerald; Stephen Morris
Journal:  EClinicalMedicine       Date:  2021-06-18

9.  Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis.

Authors:  Larissa L Fujii-Lau; Birtukan Cinnor; Nicholas Shaheen; Srinivas Gaddam; Srinadh Komanduri; V Raman Muthusamy; Ananya Das; Robert Wilson; Violette C Simon; Vladimir Kushnir; Daniel Mullady; Steven A Edmundowicz; Dayna S Early; Sachin Wani
Journal:  Endosc Int Open       Date:  2017-05-31

10.  Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.

Authors:  Rebecca C Fitzgerald; Massimiliano di Pietro; Maria O'Donovan; Roberta Maroni; Beth Muldrew; Irene Debiram-Beecham; Marcel Gehrung; Judith Offman; Monika Tripathi; Samuel G Smith; Benoit Aigret; Fiona M Walter; Greg Rubin; Peter Sasieni
Journal:  Lancet       Date:  2020-08-01       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.